RxDoctor Payments Data

Julie Bentley

Family · Johnson City, TNNPI 1164678835

Payments from drug & device makers

$1,830in general payments, 2019–2025

Across 99 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$456
  • Medtronic$331
  • Novartis$314
  • Johnson & Johnson$242
  • Abiomed$125
  • AstraZeneca$61
  • plus $301 from 9 others

What the payments were for

  • Food & beverage$1,77197%
  • Education$583%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,830 in reported general payments places this provider in the 75th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$63,673
Medicare patients
405
Services billed
716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban223$191,697
BrilintaTicagrelor32$22,779
XareltoRivaroxaban24$20,893
FarxigaDapagliflozin Propanediol29$19,370
Repatha SureclickEvolocumab13$6,983
LivaloPitavastatin Calcium14$4,835
Ranolazine ErRanolazine25$3,437
Nebivolol Hcl63$2,983
Prasugrel Hcl24$2,039
Metoprolol Succinate183$1,855
Isosorbide Mononitrate ErIsosorbide Mononitrate149$1,513
Midodrine Hcl74$1,503
Diltiazem 24hr Er (Cd)Diltiazem Hcl46$1,123
Amiodarone Hcl47$934
Bisoprolol Fumarate23$886

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$58$191,697223 claims
AstraZenecaBrilinta, Farxiga$61$42,15061 claims
Johnson & JohnsonXarelto$242$20,89324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,706 family providers in Tennessee.

Other family in Johnson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →